SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | 65.76 | 25.14 | 7.72 | 65.57 | 0.03 |
What is the latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | 65.76 |
| Mar2024 | 25.14 |
| Mar2023 | 7.72 |
| Mar2022 | 65.57 |
| Mar2017 | 0.03 |
How is Core EBITDA Growth of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | 65.76 | 161.58 | |
| Mar2024 | 25.14 | 225.65 | |
| Mar2023 | 7.72 | -88.23 | |
| Mar2022 | 65.57 | 218,466.67 | |
| Mar2017 | 0.03 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,283.1 Cr | 2.1% | 15.5% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.1% |
15.5% |
-14.4% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses